Literature DB >> 15759314

Global protein expression analysis in apicomplexan parasites: current status.

Sabina I Belli1, Robert A Walker, Sarah A Flowers.   

Abstract

Members of the phylum Apicomplexa are important protozoan parasites that cause some of the most serious, and in some cases, deadly diseases in humans and animals. They include species from the genus Plasmodium, Toxoplasma, Eimeria, Neospora, Cryptosporidium, Babesia and Theileria. The medical, veterinary and economic impact of these pathogens on a global scale is enormous. Although chemo- and immuno-prophylactic strategies are available to control some of these parasites, they are inadequate. Currently, there is an urgent need to design new vaccines or chemotherapeutics for apicomplexan diseases. High-throughput global protein expression analyses using gel or non-gel based protein separation technologies coupled with mass spectrometry and bioinformatics provide a means to identify new drug and vaccine targets in these pathogens. Protein identification based proteomic projects in apicomplexan parasites is currently underway, with the most significant progress made in the malaria parasite, Plasmodium falciparum. More recently, preliminary two-dimensional gel electrophoresis maps of Toxoplasma gondii and Neospora caninum tachyzoites and Eimeria tenella sporozoites, have been produced, as well as for micronemes in E. tenella. In this review, the status of proteomics in the analysis of global protein expression in apicomplexan parasites will be compared and the challenges associated with these investigations discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15759314     DOI: 10.1002/pmic.200401161

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  8 in total

1.  Identification of the cross-reactive and species-specific antigens between Neospora caninum and Toxoplasma gondii tachyzoites by a proteomics approach.

Authors:  Houshuang Zhang; Eung-Goo Lee; Longzheng Yu; Suguru Kawano; Penglong Huang; Min Liao; Osamu Kawase; Guohong Zhang; Jinlin Zhou; Kozo Fujisaki; Yoshifumi Nishikawa; Xuenan Xuan
Journal:  Parasitol Res       Date:  2011-04-02       Impact factor: 2.289

2.  Identification and characterization of Eimeria tenella apical membrane antigen-1 (AMA1).

Authors:  Lianlian Jiang; Jiaojiao Lin; Hongyu Han; Hui Dong; Qiping Zhao; Shunhai Zhu; Bing Huang
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

3.  Recent Progress in Functional Genomic Research in Plasmodium falciparum.

Authors:  Jianbing Mu; Karl B Seydel; Adam Bates; Xin-Zhuan Su
Journal:  Curr Genomics       Date:  2010-06       Impact factor: 2.236

4.  Comparison of protective immune responses to apicomplexan parasites.

Authors:  Sonja Frölich; Rolf Entzeroth; Michael Wallach
Journal:  J Parasitol Res       Date:  2011-08-18

5.  Molecular Characterization and Functional Analysis of a Novel Calcium-Dependent Protein Kinase 4 from Eimeria tenella.

Authors:  Ziwen Wang; Bing Huang; Hui Dong; Qiping Zhao; Shunhai Zhu; Weili Xia; Shuaibin Xu; Yuxiang Xie; Xiaoxia Cui; Min Tang; Qifei Men; Zhiyuang Yang; Cong Li; Xuelong Zhu; Hongyu Han
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

6.  Proteomic analysis of the second-generation merozoites of Eimeria tenella under nitromezuril and ethanamizuril stress.

Authors:  Xue-Yan Li; Li-Li Liu; Min Zhang; Li-Fang Zhang; Xiao-Yang Wang; Mi Wang; Ke-Yu Zhang; Ying-Chun Liu; Chun-Mei Wang; Fei-Qun Xue; Chen-Zhong Fei
Journal:  Parasit Vectors       Date:  2019-12-18       Impact factor: 3.876

Review 7.  Eimeria proteins: order amidst disorder.

Authors:  Joshua Seun Olajide; Zigang Qu; Shunli Yang; Oyeseyi Joshua Oyelade; Jianping Cai
Journal:  Parasit Vectors       Date:  2022-01-24       Impact factor: 3.876

8.  The parasite specific substitution matrices improve the annotation of apicomplexan proteins.

Authors:  Jamshaid Ali; Shashi Rekha Thummala; Akash Ranjan
Journal:  BMC Genomics       Date:  2012-12-13       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.